Tissue microarray technology for lung cancer characterization using MUC1 and Lewis Y glycoproteins

R. Wiewrodt, L. H. Schmidt, S. Biesterfeld, A. Faldum, A. Kuemmel, K. Single, R. Buhl (Mainz, Germany)

Source: Annual Congress 2006 - Lung cancer biology and chemosensitivity
Session: Lung cancer biology and chemosensitivity
Session type: Oral Presentation
Number: 2014
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Wiewrodt, L. H. Schmidt, S. Biesterfeld, A. Faldum, A. Kuemmel, K. Single, R. Buhl (Mainz, Germany). Tissue microarray technology for lung cancer characterization using MUC1 and Lewis Y glycoproteins. Eur Respir J 2006; 28: Suppl. 50, 2014

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Proteomic analysis of human small cell lung cancer tissues
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Differential expressions of MUC1 mucin with various glycosylation during lung development
Source: Annual Congress 2006 - Molecular airway biology
Year: 2006


Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010

Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Identification of tumor-associate proteins in stage-I lung squamous cancer by proteomics
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


A tissue microarray analysis on the role of chromosome 7 multiplication regarding the EGFR expression in non-small cell lung carcinomas
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016

Comparative analysis of lung cancer driver mutations from FFPE samples and liquid biopsies by IonTorrent next generation sequencing
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017

Fucosylation of serum glycoproteins in lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 458s
Year: 2005

Gene expression profiling of lung adenocarcinoma by microarray analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 93s
Year: 2005

Identifying a tissue specific microRNA molecular signature in lung cancer
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021


Specific lung cancer peptides selected by a subtractive 3D cell-phage display technology
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018


Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue
Source: Eur Respir J, 56 (3) 2001123; 10.1183/13993003.01123-2020
Year: 2020



Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009



The utility of bronchoscopically acquired tissue for successful lung cancer molecular profiling (LC-MP)
Source: Annual Congress 2013 –Comfort, safety and effectiveness of bronchoscopy
Year: 2013